Ozempic vs. Glipizide

See how Ozempic and Glipizide compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Ozempic is a once-weekly injectable GLP-1 drug that also lowers cardiovascular and kidney risk, while glipizide is a low-cost daily pill focused only on blood sugar control.

  • Ozempic's most common side effects are gastrointestinal, like nausea and vomiting, while glipizide's most common side effects are dizziness, drowsiness, and low blood sugar.

  • Glipizide costs a fraction of Ozempic's list price, but Ozempic carries added FDA approvals for heart and kidney protection that glipizide does not have.

Ozempic vs. Glipizide Drug Summary

Ozempic

Ozempic (semaglutide) is a GLP-1 receptor agonist used to control blood sugar in adults with type 2 diabetes, alongside diet and exercise. It also carries FDA approval to reduce cardiovascular risk in diabetics with heart disease and to slow kidney disease progression. It's given as a once-weekly injection under the skin.

Glipizide

Glipizide is a sulfonylurea used to control blood sugar in adults with type 2 diabetes, alongside diet and exercise. It works by stimulating the pancreas to release more insulin and has been used since 1984. It's taken as a daily oral tablet, available in immediate-release and extended-release forms.

Ozempic vs. Glipizide Side Effects

Ozempic

Most common
nausea (up to 20.3%)
vomiting (up to 9.2%)
diarrhea (up to 8.8%)
abdominal pain (up to 7.3%)

Glipizide

Most common
dizziness (up to 2%)
drowsiness (up to 2%)
headache (up to 2%)
nausea (up to 1.4%)

Ozempic vs. Glipizide Dosage

Ozempic

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 0.25 mg once weekly Weeks 1-4
Maximum dose 2 mg once weekly If needed
Dose changes 3 increases Every 4 weeks

Glipizide

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 5 mg once daily At the start
Maximum dose 5-20 mg once daily If needed
Dose changes 5 increases As tolerated

Ozempic vs. Glipizide Indications

Ozempic

Ozempic is FDA-approved for blood sugar control in type 2 diabetes, and also for reducing cardiovascular risk in diabetics with existing heart disease and slowing chronic kidney disease progression. It is not approved for weight loss, though it's sometimes prescribed off-label for that purpose. It's not for type 1 diabetes.

  • Blood sugar control in type 2 diabetes, with diet and exercise

  • Reduces heart attack, stroke, and cardiovascular death risk in known heart disease

  • Slows kidney damage progression in chronic kidney disease

  • Off-label use for weight loss in people without diabetes

Glipizide

Glipizide is FDA-approved only for blood sugar control in adults with type 2 diabetes, used alongside diet and exercise. Unlike some newer diabetes drugs, it does not carry cardiovascular or kidney-protection approvals. It's not approved for type 1 diabetes or diabetic ketoacidosis.

  • Blood sugar control in type 2 diabetes, with diet and exercise

  • No approved cardiovascular risk-reduction indication

  • No approved kidney protection indication

  • Available as immediate-release and extended-release tablets

Ozempic vs. Glipizide Pros and Cons

Ozempic

Ozempic offers added cardiovascular and kidney benefits beyond blood sugar control, but it comes with a higher price tag and a boxed warning for thyroid tumor risk seen in animal studies. Weekly dosing can be convenient, though GI side effects like nausea are common, especially during dose increases.

Pros

  • Only needs to be taken once a week

  • Also lowers cardiovascular risk in patients with heart disease

  • Also slows kidney damage progression in chronic kidney disease

  • Doesn't directly cause hypoglycemia when used alone

Cons

  • Requires a weekly injection instead of a pill

  • GI side effects like nausea and vomiting are common

  • Boxed warning for thyroid C-cell tumor risk from animal studies

  • Roughly $935 to $1,043 per month without insurance, before savings programs

Glipizide

Glipizide is inexpensive and simple to take, with decades of clinical use behind it. It doesn't offer the added cardiovascular or kidney protection of newer drugs, and it carries a higher risk of hypoglycemia than non-insulin-releasing options like Ozempic.

Pros

  • Oral tablet, no injections needed

  • Roughly $10 to $35 per month, one of the least expensive diabetes drugs

  • Long track record of safe use dating back to 1984

  • Available in immediate- and extended-release forms for flexible dosing

Cons

  • Higher risk of hypoglycemia, especially in elderly or malnourished patients

  • No added cardiovascular or kidney protection benefit

  • Sulfonylureas as a class have been linked to cardiovascular mortality concerns

  • May require more frequent daily dosing than a weekly injection

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.